[go: up one dir, main page]

DK0873134T3 - Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor - Google Patents

Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor

Info

Publication number
DK0873134T3
DK0873134T3 DK96945382T DK96945382T DK0873134T3 DK 0873134 T3 DK0873134 T3 DK 0873134T3 DK 96945382 T DK96945382 T DK 96945382T DK 96945382 T DK96945382 T DK 96945382T DK 0873134 T3 DK0873134 T3 DK 0873134T3
Authority
DK
Denmark
Prior art keywords
growth hormone
hormone releasing
releasing factor
release formulation
bovine growth
Prior art date
Application number
DK96945382T
Other languages
English (en)
Inventor
Todd P Foster
William M Moseley
James F Caputo
Michael J Hageman
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0873134T3 publication Critical patent/DK0873134T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/25Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
DK96945382T 1996-01-11 1996-12-13 Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor DK0873134T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US973896P 1996-01-11 1996-01-11
PCT/US1996/019417 WO1997025057A1 (en) 1996-01-11 1996-12-13 Aqueous prolonged release formulation

Publications (1)

Publication Number Publication Date
DK0873134T3 true DK0873134T3 (da) 2003-08-11

Family

ID=21739423

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96945382T DK0873134T3 (da) 1996-01-11 1996-12-13 Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor

Country Status (14)

Country Link
US (2) US6150330A (da)
EP (1) EP0873134B1 (da)
JP (1) JP2000506509A (da)
KR (1) KR100445087B1 (da)
CN (1) CN1130222C (da)
AT (1) ATE238063T1 (da)
CA (1) CA2240685A1 (da)
DE (1) DE69627706T2 (da)
DK (1) DK0873134T3 (da)
ES (1) ES2197258T3 (da)
HK (1) HK1016083A1 (da)
NZ (1) NZ326953A (da)
PT (1) PT873134E (da)
WO (1) WO1997025057A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130222C (zh) * 1996-01-11 2003-12-10 法玛西雅厄普约翰美国公司 水性延长释放配剂
CN1491233A (zh) * 2001-02-02 2004-04-21 康久化学公司 长效生长激素释放因子衍生物
RU2005111253A (ru) * 2002-09-18 2005-11-20 Сантр Оспиталье Де Л` Юниверсите Де Монреаль (Схюм) (Ca) Аналоги ghrh
US8871713B2 (en) 2013-03-01 2014-10-28 Theratechnologies Inc. Formulations of growth hormone releasing factor (GRF) molecules with improved stability
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
MD4037666T2 (ro) 2020-12-08 2024-09-30 Ruminant Biotech Corp Ltd Îmbunătățiri ale dispozitivelor și metodelor de furnizare a substanțelor la animale

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
US4977140A (en) * 1985-08-23 1990-12-11 Eli Lilly And Company Injectable sustained release formulation
US5756458A (en) * 1989-06-16 1998-05-26 Pharmacia & Upjohn Company Stabilized potent GRF analogs
WO1990015821A1 (en) * 1989-06-16 1990-12-27 The Upjohn Company Stabilized, potent grf analogs
IL98638A (en) * 1990-06-29 1995-07-31 Hoffmann La Roche Analogs of the factor that releases human growth hormone, their preparation and pharmaceutical preparations that contain them
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
ES2107051T3 (es) * 1992-09-21 1997-11-16 Upjohn Co Formulaciones de proteinas de liberacion sostenida.
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
CN1130222C (zh) * 1996-01-11 2003-12-10 法玛西雅厄普约翰美国公司 水性延长释放配剂

Also Published As

Publication number Publication date
DE69627706D1 (de) 2003-05-28
ATE238063T1 (de) 2003-05-15
EP0873134A1 (en) 1998-10-28
AU705466B2 (en) 1999-05-20
AU1564997A (en) 1997-08-01
DE69627706T2 (de) 2004-02-05
KR100445087B1 (ko) 2004-10-15
US6150330A (en) 2000-11-21
WO1997025057A1 (en) 1997-07-17
US6429195B1 (en) 2002-08-06
JP2000506509A (ja) 2000-05-30
CA2240685A1 (en) 1997-07-17
CN1202114A (zh) 1998-12-16
HK1016083A1 (en) 1999-10-29
EP0873134B1 (en) 2003-04-23
NZ326953A (en) 2001-03-30
CN1130222C (zh) 2003-12-10
PT873134E (pt) 2003-08-29
ES2197258T3 (es) 2004-01-01
KR19990077154A (ko) 1999-10-25

Similar Documents

Publication Publication Date Title
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
DE69434418D1 (de) Orale Dareichungsform
MY125556A (en) Aqueous formulations of peptide
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
ATE210424T1 (de) Verzoegerte freisetzung von peptiden aus pharmazeutischen zusammensetzungen
DK336986D0 (da) Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner
ES2052542T3 (es) Composiciones de hormonas del crecimiento, de liberacion sostenida, para administracion por via parenteral y su uso.
RU98117135A (ru) Композиция стабилизированного гормона роста и способ ее приготовления
GR3026564T3 (en) Use of sustained-release compositions containing GnRH, LHRH or derivatives thereof
KR870000934A (ko) 성장촉진 호르몬의 안정화 방법
DK0873134T3 (da) Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor
DE69513635D1 (de) Wässrige zubereitung mit verzögerter wirkstofffreigabe
GB8603964D0 (en) Compositions
CA2072797A1 (en) Use of tri (n-butyl) phosphate at low ph in solutions of biologically active proteins for enhanced virucidal activity
WO1998029131A3 (en) Aqueous glycerol formulations of somatotropin
EP0717625A4 (en) METHOD FOR TREATING LIVER DISEASES AND SIMILAR INDICATIONS WITH VASODILATING ACTIVE SUBSTANCES
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.
TH48412A3 (th) องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง
RU94020413A (ru) Способ осеменения животных